Rexulti (brexpiprazole) has potential interactions with alcohol and other medications. For example, Rexulti can interact with other antipsychotics, such as risperidone (Risperdal). An interaction ...

Rexulti (brexpiprazole) is a prescription drug that’s used to treat depression and other conditions related to mental health. Rexulti can cause side effects that range from mild to serious.

Rexulti has interactions with alcohol, some other drugs, and certain supplements. Examples include St. John’s wort and certain antibiotics. Before you start treatment with Rexulti, tell your ...

theU.S. Food and Drug Administration (FDA) announced Thursday. The agency said Rexulti, an oral tablet, marks thefirst FDA-approved treatment that eases agitation, which is often associated with ...

The Thursday approval of the drug, brexpiprazole (brand name Rexulti), covers the treatment of agitation associated with dementia due to Alzheimer’s. The regulatory decision is an expanded ...

Lundbeck and Otsuka’s Rexulti has become the first drug to be approved by the FDA to treat agitation associated with Alzheimer’s disease, a common symptom of the neurodegenerative disorder.

Rexulti was the first medicine approved by the ... depending on your response and other things, like drug interactions and liver or kidney function. The maximum dose is 3 milligrams each day.

The FDA will hold a joint meeting of its expert advisors to determine whether the drug Rexulti (brexpiprazole) is appropriate for use in treating agitation associated with Alzheimer’s disease ...

After Lundbeck and Otsuka’s Rexulti cleared a key advisory committee hurdle, the FDA has given the drug the go-ahead to treat dementia-associated agitation in Alzheimer’s disease patients With ...

The approval for Rexulti was made under the FDA's Fast Track designation, which speeds the review of drugs to treat serious conditions and satisfy an unmet medical need. Recommendations call for ...